- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study (clinicaltrials.gov) - May 1, 2019 P=N/A, N=31, Completed, Phase classification: P4 --> P=N/A Active, not recruiting --> Completed | Trial completion date: Sep 2017 --> Jul 2018 | Trial primary completion date: Sep 2017 --> Jul 2018
- |||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=67, Terminated, Active, not recruiting --> Completed N=120 --> 67 | Trial completion date: Dec 2024 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2023 --> Dec 2018; Business decision was made to remove the CE mark from this product, thus prompting the closing of this study.
- |||||||||| Trial completion, Trial completion date: 10003 PRO Current Products (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=842, Completed, N=120 --> 67 | Trial completion date: Dec 2024 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2023 --> Dec 2018; Business decision was made to remove the CE mark from this product, thus prompting the closing of this study. Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Aug 2018
- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial primary completion date: Vitamin D and the Free Hormone Hypothesis (clinicaltrials.gov) - Mar 26, 2019 P=N/A, N=20, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Feb 2015 --> Feb 2017
- |||||||||| eszopiclone / Generic mfg.
Enrollment change: Insomnia and Osteoarthritis Study (clinicaltrials.gov) - Mar 14, 2019 P=N/A, N=30, Completed, Active, not recruiting --> Completed | Trial primary completion date: Feb 2015 --> Feb 2017 N=105 --> 30
- |||||||||| NN1213 / Novo Nordisk
Trial completion: DePuy Attune Total Knee Arthroplasty RSA Study (clinicaltrials.gov) - Feb 1, 2019 P=N/A, N=30, Completed, Recruiting --> Completed | Trial completion date: Feb 2018 --> Feb 2019 | Trial primary completion date: Dec 2017 --> Feb 2019 Active, not recruiting --> Completed
- |||||||||| Enrollment change, Trial withdrawal: Gender Solutions Natural Knee Post-Market Study (clinicaltrials.gov) - Jan 9, 2019
P=N/A, N=0, Withdrawn, Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Aug 2018 | Trial primary completion date: Dec 2018 --> Aug 2018 N=300 --> 0 | Suspended --> Withdrawn
- |||||||||| Euflexxa (hyaluronic acid) / Ferring
Phase classification: Post-op Treatment With Hyaluronic Acid Injections (clinicaltrials.gov) - Jan 8, 2019 P=N/A, N=34, Terminated, Active, not recruiting --> Completed | Phase classification: P2/3 --> PN/A | N=250 --> 106 Phase classification: P4 --> P=N/A
- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial completion date: Use of FlexHD as Post Trapeziectomy Spacer (clinicaltrials.gov) - Jan 7, 2019 P4, N=30, Completed, Phase classification: P4 --> P=N/A Active, not recruiting --> Completed | Trial completion date: Mar 2017 --> Dec 2017
- |||||||||| NN1213 / Novo Nordisk
Trial completion: Regenexx (clinicaltrials.gov) - Jan 4, 2019 P=N/A, N=48, Completed, Active, not recruiting --> Completed | Trial completion date: Mar 2017 --> Dec 2017 Active, not recruiting --> Completed
- |||||||||| Trial completion, Phase classification, Enrollment change: Augment (clinicaltrials.gov) - Dec 5, 2018
P=N/A, N=299, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P3 --> PN/A | N=201 --> 299
- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Supine Sleeping After Total Hip Replacement (clinicaltrials.gov) - Nov 27, 2018 P=N/A, N=456, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Mar 2020 --> Mar 2018 | Trial primary completion date: Mar 2019 --> Mar 2018
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: PAS:IDE: Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects (clinicaltrials.gov) - Nov 19, 2018
P=N/A, N=350, Completed, N=350 --> 231 Active, not recruiting --> Completed | Trial completion date: Mar 2018 --> Aug 2017 | Trial primary completion date: Mar 2018 --> Jun 2017
- |||||||||| NN1213 / Novo Nordisk
Trial completion: Facet Wedge Post Market Study (clinicaltrials.gov) - Oct 19, 2018 P=N/A, N=50, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Trial completion date, Trial termination, Trial primary completion date: Clinical Outcomes of Knee Replacement (clinicaltrials.gov) - Sep 26, 2018
P=N/A, N=316, Terminated, Active, not recruiting --> Completed | Phase classification: P1 --> PN/A Trial completion date: Feb 2028 --> Sep 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2026 --> Sep 2018; Changes in funding.
- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date, Adverse events: Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions (clinicaltrials.gov) - Sep 25, 2018 P=N/A, N=3000, Completed, Trial completion date: Feb 2028 --> Sep 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2026 --> Sep 2018; Changes in funding. Recruiting --> Completed | Trial completion date: Mar 2018 --> Jan 2017 | Trial primary completion date: Mar 2018 --> Dec 2016
- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial completion date, Surgery: Occupational Therapy and Surgery in Carpometacarpal Osteoarthritis (clinicaltrials.gov) - Aug 31, 2018 P=N/A, N=180, Completed, Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> May 2017 Active, not recruiting --> Completed | Trial completion date: Dec 2019 --> Aug 2018
- |||||||||| NN1213 / Novo Nordisk
Trial completion: Efficacy and Safety of NEM (clinicaltrials.gov) - Aug 22, 2018 P=N/A, N=166, Completed, Trial completion date: Jul 2018 --> Dec 2018 | Trial primary completion date: Jul 2018 --> Dec 2018 Recruiting --> Completed
- |||||||||| Enrollment change, Trial withdrawal: Follow up Study of Patients Undergoing Total Hip Arthroplasty CERAFIT (clinicaltrials.gov) - Aug 14, 2018
P1/2, N=0, Withdrawn, Active, not recruiting --> Completed | N=60 --> 32 | Trial completion date: Jan 2017 --> Jan 2018 | Trial primary completion date: Jan 2017 --> Mar 2016 N=50 --> 0 | Not yet recruiting --> Withdrawn
|